Bench To The Clinic: Biomanufacturing 101 For University Researchers
University researchers looking to translate their lab discoveries into practical applications in a clinical setting face complex hurdles. Leveraging the support of a biologics contract development and manufacturing organization (CDMO) experienced in clinical manufacturing can help with process development and tech transfer. When selecting a CDMO, factors such as location and size should be considered. A U.S.-based CDMO promotes collaboration and may be required for funding from government programs, while a smaller, boutique CDMO can provide more personalized attention and expertise.
This article explores the essential role a CDMO plays in transforming promising research into tangible clinical trial materials. You'll learn how a CDMO can:
- Provide the cGMP facilities and expertise crucial for clinical manufacturing
- Navigate the complexities of scaling up production from lab quantities to clinical trial needs
- Ensure a smooth technology transfer process, minimizing delays and disruptions
- Offer project management and scientific guidance throughout the journey
Don't let the challenges of clinical translation stall your research. This article equips you with the knowledge to shepherd your innovation from the university lab to the clinic, ultimately realizing the potential to improve patients' lives.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.